Sotorasib resistance in KRAS G12C-mutant invasive mucinous adenocarcinoma with implications for VEGF-A
Hiraku Yanada(Asahikawa Medical University), Takaaki Sasaki(Asahikawa Medical College Hospital)
Cited by 1
Related Papers
Administration of VEGF receptor tyrosine kinase inhibitor increases VEGF production causing angiogenesis in human small-cell lung cancer xenografts
|International Journal of Oncology|1992|15
Cyclin-dependent kinase 4 upregulation mediates acquired resistance of dabrafenib plus trametinib in BRAF V600E-mutated lung cancer
|Translational Lung Cancer Research|2021|11